News + Filings Transactions Holdings
All 13F 13D/G Other
|
5AM VENTURES III, L.P.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/05/2020 |
SC 13G/A
| 5AM VENTURES III, L.P. reports a 3.6% stake in Arvinas, Inc. |
09/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/11/2019 |
4
| 5AM VENTURES III, L.P. (10% Owner) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 185,226 shares
@ $19.65, valued at
$3.6M
Sold 4,774 shares
@ $19.65, valued at
$93.8k
|
|
04/01/2019 |
4
| 5AM VENTURES III, L.P. (10% Owner) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 352,056 shares
@ $14.1575, valued at
$5M
Sold 9,073 shares
@ $14.1575, valued at
$128.5k
|
|
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2019 |
SC 13G
| 5AM VENTURES III, L.P. reports a 15.4% stake in Arvinas, Inc. |
10/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/26/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/08/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
04/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/14/2017 |
SC 13G
| 5AM VENTURES III, L.P. reports a 11% stake in Audentes Therapeutics, Inc. |
02/14/2017 |
SC 13G/A
| 5AM VENTURES III, L.P. reports a 12.1% stake in Cidara Therapeutics, Inc. |
07/19/2016 |
3
| 5AM Partners III, LLC (10% Owner) has filed a Form 3 on Audentes Therapeutics, Inc. |
02/11/2016 |
SC 13G
| 5AM VENTURES III, L.P. reports a 14.6% stake in Cidara Therapeutics, Inc. |
07/24/2015 |
SC 13D/A
| 5AM VENTURES III, L.P. reports a 4.8% stake in Relypsa, Inc. |
04/22/2015 |
4
| ROCKLAGE SCOTT M (10% Owner) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns:
| Converted 1,764,195 shares
@ $0 Converted 45,467 shares
@ $0 Converted 1,764,195 convertible preferred
@ $0 Converted 45,467 convertible preferred
@ $0 |
|
03/27/2015 |
SC 13D/A
| 5AM VENTURES III, L.P. reports a 5.9% stake in Relypsa, Inc. |
02/09/2015 |
SC 13D/A
| 5AM VENTURES III, L.P. reports a 11.7% stake in EPIRUS Biopharmaceuticals, Inc. |
02/06/2015 |
4
| 5AM Partners III, LLC (10% Owner) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.
Txns:
| Bought 10,050 shares
@ $5, valued at
$50.3k
Bought 389,950 shares
@ $5, valued at
$1.9M
|
|
12/11/2014 |
SC 13D/A
| 5AM VENTURES III, L.P. reports a 9.4% stake in Sc 13d/a Relypsa, Inc. |
12/11/2014 |
4
| 5AM Partners III, LLC (10% Owner) has filed a Form 4 on Relypsa Inc
Txns:
| Sold 574,823 shares
@ $30.04, valued at
$17.3M
Sold 14,814 shares
@ $30.04, valued at
$445k
|
|
09/17/2014 |
SC 13D/A
| 5AM VENTURES III, L.P. reports a 11.2% stake in Relypsa, Inc. |
09/03/2014 |
SC 13D/A
| 5AM VENTURES III, L.P. reports a 13% stake in Relypsa, Inc. |
08/29/2014 |
SC 13D
| 5AM VENTURES III, L.P. reports a 17.3% stake in EPIRUS Biopharmaceuticals, Inc. |
07/30/2014 |
SC 13D
| 5AM VENTURES III, L.P. reports a 14.3% stake in Relypsa, Inc. |
11/20/2013 |
4
| 5AM Partners III, LLC (10% Owner) has filed a Form 4 on Relypsa Inc
Txns:
| Converted 1,234,230 shares
@ $0 Converted 284,822 shares
@ $0 Exercised 442,160 shares
@ $0.17, valued at
$75.2k
Paid exercise price by delivering 6,914 shares
@ $11, valued at
$76.1k
Exercised 102,036 shares
@ $0.17, valued at
$17.3k
Paid exercise price by delivering 1,596 shares
@ $11, valued at
$17.6k
Bought 363,328 shares
@ $11, valued at
$4M
Converted 31,809 shares
@ $0 Converted 7,340 shares
@ $0 Exercised 11,395 shares
@ $0.17, valued at
$1.9k
Paid exercise price by delivering 179 shares
@ $11, valued at
$2k
|
|
12/11/2009 |
D/A
| Form D - Notice of Exempt Offering of Securities [amend] |
07/01/2009 |
D/A
| Form D/A -- Notice of Exempt Offering of Securities [amend] |
|
|